Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Prokineticin Receptor 1 ELISA Kit (AC2704)
Cat.#: ASET-1293
Specifications
Description Rat Prokineticin Receptor 1 ELISA Kit allows for the in vitro quantitative determination of rat Prokineticin Receptor 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-1861 Human Nkx2.5 ELISA Kit (AC3272) Quantitative inquiry ASET-1964 Human Prol1 ELISA Kit (AC3375) Quantitative inquiry ASET-1958 Human P311 ELISA Kit (AC3369) Quantitative inquiry ASET-2137 Human Nicastrin ELISA Kit (AC3548) Quantitative inquiry ASET-1150 Mouse Galectin 3 ELISA Kit (AC2561) Quantitative inquiry ASET-1512 Human P2Y1 ELISA Kit (AC2923) Quantitative inquiry ASET-1515 Human CHRNA10 ELISA Kit (AC2926) Quantitative inquiry ASET-1997 Human Stathmin 1 ELISA Kit (AC3408) Quantitative inquiry ASET-1733 Human GFAP ELISA Kit (AC3144) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket